GyroStim is used for patients recovering from concussion and traumatic brain injury, as well as those managing ongoing balance and vestibular disorders, dizziness, and other neurological conditions. It is also used by athletes looking to enhance sports performance through improved vestibular processing, reaction time, and coordination. Candidates for GyroStim therapy include people experiencing symptoms related to head injury, illness, advanced age, or neurological conditions that affect balance and cognitive function. A provider evaluation is the best way to determine whether GyroStim is appropriate for a specific patient’s condition and goals.

Neuroscience Group is proud to offer the only GyroStim machine in Wisconsin. GyroStim therapy is available at Neuroscience Group’s clinic in Northeast Wisconsin, serving patients from Appleton, Neenah, the Fox Valley, Green Bay, and surrounding communities. As the state’s only provider of this FDA Breakthrough Device-designated technology, Neuroscience Group is the destination for patients across Wisconsin seeking GyroStim treatment. To find out if GyroStim is right for you, contact Neuroscience Group to request an evaluation.

If you are in Wisconsin or the Upper Midwest, Neuroscience Group in Northeast Wisconsin is the only clinic in the state offering GyroStim therapy. Located in Neenah and Appleton, Neuroscience Group serves patients from across the Fox Valley, Green Bay, Fond du Lac, and the broader Northeast Wisconsin region. Patients traveling from outside the immediate area are encouraged to contact Neuroscience Group to discuss their situation and determine whether GyroStim evaluation is worth the trip. To request an appointment, use the online form on the GyroStim page or call Neuroscience Group directly.

GyroStim is used to treat a range of neurological and vestibular conditions, including concussion and post-concussion syndrome, traumatic brain injury, balance and vestibular disorders, dizziness and vertigo, and other neurological conditions affecting coordination and cognitive function. It is also used as a performance enhancement tool for athletes seeking improved reaction time, spatial awareness, and vestibular processing. Because GyroStim works by stimulating neuroplasticity, it is effective across a broad spectrum of patients, from those recovering from acute injury to those managing long-term neurological symptoms.

During a GyroStim session, the patient is seated in the rotating chair, which is programmed to move in multiple directions and at varying speeds tailored to their current level of function. As the chair moves, patients respond to visual targets, engaging their balance, coordination, and cognitive processing at the same time. Sessions are carefully calibrated and progressively challenging, building on each previous session to promote continued neurological adaptation. The therapy is non-invasive and is typically delivered as a series of sessions over a defined treatment period. Your Neuroscience Group provider will design a GyroStim protocol based on your diagnosis, symptoms, and rehabilitation goals.

GyroStim has received FDA Breakthrough Device designation, which is a classification reserved for medical devices that provide more effective treatment or diagnosis of serious conditions compared to existing options. This designation reflects the clinical promise of GyroStim for patients with neurological conditions, concussion, and traumatic brain injury. Neuroscience Group is the only clinic in Wisconsin offering this technology, making it the regional destination for patients seeking this level of advanced neurological care.

Traditional vestibular therapy typically involves exercises performed by the patient on their own or with a therapist, targeting the vestibular system through controlled head and body movements. GyroStim takes this further by delivering precise, multi-directional rotational input through a motorized chair while simultaneously challenging the patient’s cognitive and visual responses. This combination of controlled sensory stimulation and active cognitive engagement is designed to accelerate neuroplasticity in ways that standard vestibular exercises cannot replicate. For patients who have not responded fully to traditional vestibular rehabilitation, GyroStim offers an advanced alternative at Neuroscience Group’s Northeast Wisconsin clinic.

To get started, contact Neuroscience Group to request an evaluation. A provider will review your medical history, current symptoms, and treatment goals to determine whether GyroStim is appropriate for your condition. Neuroscience Group’s team includes specialists in neurology, vestibular rehabilitation, and concussion care who work together to develop a coordinated treatment plan. You can request an appointment online or call Neuroscience Group directly. The Neenah and Appleton clinics serve patients from across Northeast Wisconsin, including the Fox Valley, Green Bay, and Fond du Lac regions.

At this time, it is a cash pay treatment. We are hoping with continued research, eventually insurance will agree to pay. It is $180 per session, and a patient is required to speak with our billing department and agree to a payment contract. If a patient chooses to pay for all 10 sessions in advance, a 7% discount is applied. If a patient paid in advance, and it is clinically determined that a patient is not tolerating GyroStim treatments, a refund will be given for unused sessions.

We recommend 10 sessions to start. Any session will have benefit to a patient, but just like other therapies, practice makes perfect and helps reinforce gains. Some patients will improve quickly, and some will take more time. Continuing and doing more sessions is always a possibility, and our providers are in regular communication about what is best for the patient.

GyroStim is part of our comprehensive concussion clinic; we do not recommend using it alone. While it is a valuable tool, it works best in conjunction with physical therapy, speech therapy and occupational therapy. It helps reinforce the exercises and treatments patients are doing with their therapists. It is also important to rule out other challenges and safety concerns, such as BPPV and significant vision impairments before starting GyroStim treatments. If a patient is struggling with either of those, it is difficult to proceed very far with GyroStim treatments as it will limit their ability to handle increased stimulation and can worsen their symptoms. It is a team effort to safely and effectively treat the patient.